How Precisely Can Prostate Cancer Be Managed?
Liyan Zhuang, Matthew T. Johnson
Int Neurourol J. 2016;20(Suppl 2):S120-130.   Published online 2016 Nov 22
DOI: https://doi.org/10.5213/inj.1632724.362
Citations to this article as recorded by
  Crossref logo
Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)
David Albala, Michael S. Manak, Jonathan S. Varsanik, Hani H. Rashid, Vladimir Mouraviev, Stephen M. Zappala, Ene Ette, Naveen Kella, Kimberly M. Rieger-Christ, Grannum R. Sant, Ashok C. Chander
Urology.2019; 124: 198.     CrossRef
Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer
David Pasquier, Abderraouf Hadj Henni, Alexandre Escande, Emmanuelle Tresch, Nick Reynaert, Olivier Colot, Eric Lartigau, Nacim Betrouni
Scientific Reports.2018;[Epub]     CrossRef
Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence
Yanzhi Jiang, Wenjuan Mei, Yan Gu, Xiaozeng Lin, Lizhi He, Hui Zeng, Fengxiang Wei, Xinhong Wan, Huixiang Yang, Pierre Major, Damu Tang
Molecular Oncology.2018; 12(9): 1559.     CrossRef
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning
Michael S. Manak, Jonathan S. Varsanik, Brad J. Hogan, Matt J. Whitfield, Wendell R. Su, Nikhil Joshi, Nicolai Steinke, Andrew Min, Delaney Berger, Robert J. Saphirstein, Gauri Dixit, Thiagarajan Meyyappan, Hui-May Chu, Kevin B. Knopf, David M. Albala, Gr
Nature Biomedical Engineering.2018; 2(10): 761.     CrossRef
Wie weit sind die molekularen Marker beim Prostatakarzinom?
Karl Pummer
Journal für Urologie und Urogynäkologie/Schweiz.2017; 19(4): 103.     CrossRef
Wie weit sind die molekularen Marker beim Prostatakarzinom?
Karl Pummer
Journal für Urologie und Urogynäkologie/Österreich.2017; 24(4): 111.     CrossRef
Are We Ready to Use the Omics Strategies for Precision Medicine?
Jayoung Kim
International Neurourology Journal.2016; 20(Suppl 2): S65.     CrossRef